ReIGNITE RT Boost: An international study testing the accuracy and feasibility of using restriction spectrum imaging (RSI) MRI to guide intraprostatic tumor target volume for radiotherapy boost

Asona J. Lui, Karoline Kallis, Allison Y. Zhong, Troy S. Hussain, Christopher Conlin, Leonardino A. Digma, Nikki Phan, Ian T. Mathews, Deondre D. Do, Mariluz Rojo, Roshan Karunamuni, Joshua Kuperman, Anders M. Dale, Rebecca Rakow-Penner, Michael E. Hahn, Tyler M. Seibert
doi: https://doi.org/10.1101/2022.12.13.22283420

Article usage

Article usage: December 2022 to July 2025

AbstractFullPdf
Dec 20223891442
Jan 20236739
Feb 20233748
Mar 202339011
Apr 20233228
May 20232445
Jun 20231642
Jul 20231414
Aug 2023241210
Sep 20231762
Oct 2023740
Nov 20231352
Dec 20231905
Jan 20241005
Feb 20241923
Mar 20241307
Apr 202419715
May 20241404
Jun 2024913
Jul 20249213
Aug 202418219
Sep 202417412
Oct 202414218
Nov 202415012
Dec 2024603
Jan 20251144
Feb 202522119
Mar 2025351712
Apr 202537110
May 20252369
Jun 202536108
Jul 20251488
Back to top
Posted December 14, 2022.
Download PDF
Data/Code
Email
ReIGNITE RT Boost: An international study testing the accuracy and feasibility of using restriction spectrum imaging (RSI) MRI to guide intraprostatic tumor target volume for radiotherapy boost
Asona J. Lui, Karoline Kallis, Allison Y. Zhong, Troy S. Hussain, Christopher Conlin, Leonardino A. Digma, Nikki Phan, Ian T. Mathews, Deondre D. Do, Mariluz Rojo, Roshan Karunamuni, Joshua Kuperman, Anders M. Dale, Rebecca Rakow-Penner, Michael E. Hahn, Tyler M. Seibert
medRxiv 2022.12.13.22283420; doi: https://doi.org/10.1101/2022.12.13.22283420
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area